Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Breast Care (Basel, Switzerland)|July 19, 2019
Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer PatientsMattea Reinisch, Oleg Gluz, Beyhan Ataseven, et al.
Archives of Gynecology and Obstetrics|November 1, 2021
The role of factor XIII in surgery for advanced stage of epithelial ovarian cancerMahtab Yazdian, Harald Groeben, Beyhan Ataseven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2024
2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or bothEric Rios-Doria, Nadeem R Abu-Rustum, Gretchen Glaser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or bothEric Rios-Doria, Nadeem R Abu-Rustum, Gretchen Glaser, et al.
Gynecologic Oncology|March 3, 2020
Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumorsHelmut Plett, Philipp Harter, Beyhan Ataseven, et al.
Cancers|May 13, 2023
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma PatientsMajdi Imterat, Philipp Harter, Kerstin Rhiem, et al.
Oncology Research and Treatment|November 29, 2020
Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?Kemal Güngördük, Helmut Plett, Varol Gülseren, et al.
Gynecologic Oncology|November 23, 2018
Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancerSonia Prader, Nils Vollmar, Andreas du Bois, et al.
Cancers|February 11, 2023
Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian CancerFlorian Heitz, Beyhan Ataseven, Claudia Staniczok, et al.
Archives of Gynecology and Obstetrics|March 4, 2021
Response evaluation after neoadjuvant therapy: evaluation of chemotherapy response score and serological and/or radiological assessment of response in ovarian cancer patientsJan Philipp Ramspott, Thaïs Baert, Michelle Louise MacKintosh, et al.
Pageof 11